Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In a 12-month clinical trial involving 404 HIV-infected patients with excess abdominal fat, Tesamorelin (2 mg daily) significantly reduced visceral adipose tissue (VAT) compared to placebo
Recovery time is faster, energy levels are up and muscle is being maintained while loosing noticeable fat in the midsection
16.74 mmol/mol creatine, p = 0.001), but a mild nonsignificant decrease in urine carnitine was observed in high-TMAO producers (17.18 vs
These possible effects of Tesamorelin may benefit specific patient populations
Another avenue of use stems from immune system support
142C7785
US$ 27.44
US$ 21.09
US$ 21.54
US$ 21.24
US$ 28.49
US$ 22.67
US$ 20.16
US$ 27.24
US$ 23.21
